Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Ravi B. Diwakar"'
Autor:
Aruna Korlimarla, PS Hari, Jyoti Prabhu, Chanthirika Ragulan, Yatish Patil, VP Snijesh, Krisha Desai, Aju Mathews, Sandhya Appachu, Ravi B. Diwakar, BS Srinath, Alan Melcher, Maggie Cheang, Anguraj Sadanandam
Publikováno v:
Translational Oncology, Vol 27, Iss , Pp 101574- (2023)
Externí odkaz:
https://doaj.org/article/8af7d49800d6483188b46b69120e86c7
Autor:
Aruna Korlimarla, Hari PS, Jyoti Prabhu, Chanthirika Ragulan, Yatish Patil, Snijesh VP, Krisha Desai, Aju Mathews, Sandhya Appachu, Ravi B. Diwakar, Srinath BS, Alan Melcher, Maggie Cheang, Anguraj Sadanandam
Publikováno v:
Translational Oncology, Vol 25, Iss , Pp 101511- (2022)
Purpose: Triple-negative breast cancer (TNBC) is a heterogeneous disease with a significant challenge to effectively manage in the clinic worldwide. Immunotherapy may be beneficial to TNBC patients if responders can be effectively identified. Here we
Externí odkaz:
https://doaj.org/article/a88adf8242244906823d8dcfed4bdb5f
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:HSR22-123
Autor:
Aruna Korlimarla, PS Hari, Jyoti Prabhu, Chanthirika Ragulan, Yatish Patil, VP Snijesh, Krisha Desai, Aju Mathews, Sandhya Appachu, Ravi B. Diwakar, BS Srinath, Maggie Cheang, Anguraj Sadanandam
BackgroundTriple-negative breast cancer (TNBC) is a heterogeneous disease with a significant clinical challenge. TNBC alarmingly comprises 25-30% of breast cancers in India compared with only 10-15% in the West. However, immunotherapy was approved fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41218f739a5fc7fe90eebb5dd0d0ac59
https://doi.org/10.1101/2022.03.06.483159
https://doi.org/10.1101/2022.03.06.483159
Autor:
Aruna Korlimarla, Hari PS, Jyothi S Prabhu, Chantirika Ragulan, Ravi B Diwakar, Sandhya Apachu, Maggie Cheang, Rekha V Kumar, BS Srinath, TS Sridhar, Savitha Rajarajan, Annie Alexander, Anguraj Sadanandam
Publikováno v:
Cancer Research. 82:P5-06
Introduction: Triple-Negative Breast Cancer (TNBC) comprises approximately 30% of all breast cancers in Indian women. Given their aggressive nature, TNBCs have high rates of systemic metastasis and mortality with only chemotherapy available for treat
Autor:
Shekhar Patil, Raghuram Nagarathna, Basavalinga S. Ajaikumar, H S Vadiraja, Ravi B Diwakar, Raghavendra M Rao, Kodaganur S. Gopinath, H R Nagendra, H P Shashidhara
Publikováno v:
Indian Journal of Palliative Care, Vol 23, Iss 3, Pp 247-252 (2017)
Indian Journal of Palliative Care
Indian Journal of Palliative Care
Background: Cancer-related fatigue is widely prevalent in cancer patients and affects quality of life in advanced cancer patients. Fatigue is caused due to both psychologic distress and physiological sequel following cancer progression and its treatm
Autor:
Hongasandra Ramarao Nagendra, Ramesh S Bilimagga, Shekhar Patil, Ravi B Diwakar, Nagaratna Raghuram, Raghavendra M Rao, H P Shashidhara, Nalini Rao, Gopinath S Kodaganur
Publikováno v:
Indian Journal of Palliative Care
Indian Journal of Palliative Care, Vol 23, Iss 3, Pp 237-246 (2017)
Indian Journal of Palliative Care, Vol 23, Iss 3, Pp 237-246 (2017)
Aims: The aim of this study is to compare the effects of yoga program with supportive therapy counseling on mood states, treatment-related symptoms, toxicity, and quality of life in Stage II and III breast cancer patients on conventional treatment. M
Autor:
HP Shahsidhara, Basavalinga S. Ajaikumar, H S Vadiraja, Raghavendra M Rao, Kodaganur S. Gopinath, H R Nagendra, R Nagaratna, Shekhar Patil, Ravi B Diwakar
Publikováno v:
Indian Journal of Palliative Care
Indian Journal of Palliative Care, Vol 23, Iss 3, Pp 253-260 (2017)
Indian Journal of Palliative Care, Vol 23, Iss 3, Pp 253-260 (2017)
Background: Studies have shown that distress and accompanying neuroendocrine stress responses as important predictor of survival in advanced breast cancer patients. Some psychotherapeutic intervention studies have shown have modulation of neuroendocr
Autor:
BS Kumar, H P Shashidhara, Rao, A Gangoli, Shivanand Patil, Ravi B Diwakar, Shilpa Prabhudesai, C T Satheesh, J Dixit, Diganta Hazarika, R Tejaswi, S Kakara, Vidya H Veldore, N Krishnamoorthy, KS Gopinath, Shamir Rahman, Radheshyam Naik, Subhrendu K. Pattanayak, Tejaswini Bn
Publikováno v:
Indian journal of cancer. 51(4)
Background: One of the genetic alterations implicated in tumor progression in colorectal cancers (CRCs) are abnormalities in Kristen Rat Sarcoma (KRAS) gene. Evaluation of KRAS mutation status is an important prognostic factor and has predictive valu
Autor:
S A Gangoli, R Tejaswi, Shamir Rahman, Shilpa Prabhudesai, C T Satheesh, S Patil, Raghavendra M Rao, Diganta Hazarika, Radheshyam Naik, Tejaswini Bn, Ravi B Diwakar, S Kakara, Rashmita Sahoo, Vidya H Veldore, Subhrendu K. Pattanayak, S P Shashidhar, E Venkataswamy, N Krishnamoorthy, B S Ajai Kumar
Publikováno v:
Indian journal of cancer. 50(2)
Background: Epidermal growth factor receptor (EGFR) mutation plays a vital role in the prognosis of patients with lung cancer. However, there is a dearth of studies on EGFR mutation in Indian population. In this retrospective study conducted at a net